Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

163
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
163
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

180
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
180
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K
Inhaled Medications01:23

Inhaled Medications

210
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
210
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Safety of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis with Diabetes: Pooled Subgroup Analysis of reSURFACE 1 and reSURFACE 2.

Dermatology and therapy·2026
Same author

Sex Differences in Outcomes of Complex Percutaneous Coronary Interventions Assisted With Mechanical Circulatory Support Devices.

JACC. Advances·2026
Same author

A CAPTURE ancillary study to assess GOLD 2025 spirometry recommendations in primary care adults.

Annals of the American Thoracic Society·2026
Same author

Primary care provider referral patterns and awareness of biologic therapy for uncontrolled asthma.

The journal of allergy and clinical immunology. Global·2026
Same author

Social Determinants of Health and Pediatric Long COVID in the US.

JAMA pediatrics·2026
Same author

Screening for Firearm Violence Exposure in Adolescents and Young Adults.

Journal of the American Board of Family Medicine : JABFM·2026

Related Experiment Video

Updated: May 20, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.5K

Adverse Outcomes Associated With Inhaled Corticosteroid Use in Individuals With Chronic Obstructive Pulmonary

Wilson D Pace1, Elisabeth Callen2, Gabriela Gaona-Villarreal2

  • 1DARTNet Institute, Aurora, Colorado Wilson.pace@dartnet.info.

Annals of Family Medicine
|March 24, 2025
PubMed
Summary

Long-term use of inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease (COPD) management significantly increases risks for serious health issues, including diabetes, pneumonia, and fractures.

Keywords:
chronic obstructive pulmonary diseaseinhaled corticosteroidstreatment outcomes

More Related Videos

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

560
Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
05:34

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders

Published on: August 18, 2023

2.0K

Related Experiment Videos

Last Updated: May 20, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.5K
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

560
Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
05:34

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders

Published on: August 18, 2023

2.0K

Area of Science:

  • Pulmonary Medicine
  • Pharmacovigilance
  • Clinical Epidemiology

Background:

  • Chronic obstructive pulmonary disease (COPD) management often involves inhaled corticosteroids (ICS).
  • Understanding the long-term safety profile of ICS is crucial for optimizing COPD treatment strategies.
  • Previous studies have suggested potential adverse effects associated with ICS use.

Purpose of the Study:

  • To evaluate the long-term risks associated with inhaled corticosteroid (ICS) use in patients with chronic obstructive pulmonary disease (COPD).
  • To compare the incidence of specific adverse outcomes between long-term and short-term ICS exposure in COPD patients.

Main Methods:

  • Electronic health record data from individuals over 45 years old with COPD were analyzed.
  • Two cohorts, prevalent and inception, were defined based on COPD diagnosis timing.
  • A composite outcome (type 2 diabetes, cataracts, pneumonia, osteoporosis, fracture) and recurrent events (pneumonia, fracture) were compared between long-term (>24 months) and short-term (<4 months) ICS users.

Main Results:

  • The study included 318,385 (prevalent) and 209,062 (inception) individuals.
  • Long-term ICS use was significantly associated with a higher composite outcome in both prevalent (HR=2.65) and inception (HR=2.60) cohorts.
  • Increased risks were observed for recurrent pneumonia and recurrent fractures in both cohorts with long-term ICS exposure.

Conclusions:

  • Long-term inhaled corticosteroid (ICS) therapy for COPD is linked to substantially higher rates of major adverse events.
  • These risks include type 2 diabetes, cataracts, pneumonia, osteoporosis, and fractures.
  • The findings highlight the importance of careful consideration of ICS duration in COPD management.